Chest
EditorialsCoexisting Asthma and COPD: Confused Clinicians or Poor Prognosticator?
References (12)
- et al.
Obstructive lung diseases: COPD, asthma, and many imitators
Mayo Clin Proc
(2001) - et al.
Burden of concomitant asthma and COPD in a Medicaid population
Chest
(2008) - et al.
The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom
Chest
(2003) - et al.
Mortality and markers of risk of asthma death among 1,075 outpatients with asthma
Chest
(1995) Differences and similarities between chronic obstructive pulmonary disease and asthma
Clin Exp Allergy
(1999)- et al.
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary
Am J Respir Crit Care Med
(2007)
Cited by (6)
Comorbidome, pattern, and impact of asthma-COPD overlap syndrome in real life
2016, ChestCitation Excerpt :We used all comorbidities as available in the administrative database, but not validated indices such as the Charlson comorbidity index34 or COTE (COPD specific comorbidity test) index.27 Finally, note that patients with more health-care use may have more chance to get a double diagnosis.35 To date, a number of literature reviews have covered ACOS, including its pharmacotherapy and physiological properties.6,10,23,36-40
The asthma-COPD overlap syndrome: Towards a revised taxonomy of chronic airways diseases?
2015, The Lancet Respiratory MedicineCitation Excerpt :When ACOS is defined on the basis of a doctor diagnosis of both asthma and COPD, its prevalence in different cohorts of patients aged 40 years and older with chronic airways disease—including the US NHANES III study,14 the UK GP Research Database,15 and other studies in the USA,16 Italy,11 and Finland12—is in the range of 15–20%. However, in patients with chronic asthma, physicians are probably biased towards adding a diagnosis of COPD with increasing age and in those who have features of chronic irreversible airflow limitation, are symptomatic with this disease and therefore need additional treatment.17 This tendency is suggested by the lower proportions diagnosed with asthma alone in older age groups (eg, 65–84 years) than in younger age groups (eg, 20–44 years).11
Understanding COPD-overlap syndromes
2017, Expert Review of Respiratory MedicineHistory of asthma in patients with chronic obstructive pulmonary disease a comparative study of economic burden
2016, Annals of the American Thoracic SocietyRegular inhaled corticosteroids in adult-onset asthma and the risk for future cancer: A population-based cohort study with proper person-time analysis
2015, Therapeutics and Clinical Risk ManagementSignificant bronchodilator responsiveness and "reversibility" in a population sample
2010, COPD: Journal of Chronic Obstructive Pulmonary Disease
Reproduction of this article is prohibited without written permission from the American College of Chest Physicians (www.chestjournal.org/misc/reprints.shtml).
- 1
Dr. Mannino is from the Department of Preventive Medicine and Environmental Health, University of Kentucky College of Public Health.
- 2
Dr. Mannino has received research grants from GlaxoSmithKline, Pfizer, and Novartis, and serves as a consultant to GlaxoSmithKline, Pfizer, Boehringer-Ingelheim, Astra-Zeneca, Dey, Sepracor, and Novartis.